+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Brain Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Brain Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
TRK Fusion Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

TRK Fusion Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
MDS - Pipeline Insight, 2025 - Product Thumbnail Image

MDS - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HR-Positive-HER-negative - Pipeline Insight, 2025 - Product Thumbnail Image

HR-Positive-HER-negative - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Adult R/R RAF-Altered Solid Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Adult R/R RAF-Altered Solid Tumors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
mTORC-2 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

mTORC-2 Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Retinoic Acid Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Retinoic Acid Receptor Agonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
TGF-Beta Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

TGF-Beta Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Multiple Myeloma-related Bone Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Multiple Myeloma-related Bone Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Natural Killer (NK)-Cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Natural Killer (NK)-Cell Lymphoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 100 Pages
  • Global
From
PTCL-NOS - Pipeline Insight, 2025 - Product Thumbnail Image

PTCL-NOS - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
T-Cell Prolymphocytic Leukemia (T-PLL) - Pipeline Insight, 2025 - Product Thumbnail Image

T-Cell Prolymphocytic Leukemia (T-PLL) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Clear Cell Renal Cell Carcinoma (ccRCC) - Pipeline Insight, 2025 - Product Thumbnail Image

Clear Cell Renal Cell Carcinoma (ccRCC) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
DDR Defect Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

DDR Defect Tumors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Mucinous Cystic Neoplasm - Pipeline Insight, 2025 - Product Thumbnail Image

Mucinous Cystic Neoplasm - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 50 Pages
  • Global
From
Desmoplastic Small Round Cell Tumor - Pipeline Insight, 2025 - Product Thumbnail Image

Desmoplastic Small Round Cell Tumor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
GPCR-Targeting Therapies - Pipeline Insight, 2025 - Product Thumbnail Image

GPCR-Targeting Therapies - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Leptomeningeal Metastases - Pipeline Insight, 2025 - Product Thumbnail Image

Leptomeningeal Metastases - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Metastatic Castration-Sensitive Prostate Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Castration-Sensitive Prostate Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more